HCW Biologics Inc.: which funds bought and sold
Institutions that bought and sold HCW Biologics shares in Q2 2026, from the holdings they reported to the SEC on Form 13F for March 31, 2026 and June 30, 2026.
Between March 31, 2026 and June 30, 2026, 11 institutions that filed 13F reports for both quarters added to or opened positions in HCW Biologics, and 0 cut or closed them. Together they added a net 103K shares, — on what they held at the start of the quarter. Active managers and hedge funds on our list were net buyers of 20K shares; index fund managers were net buyers of 8,513 shares. 11 opened a new position and 0 sold out entirely.
Bought, Q2 2026 11 institutions, 11 of them new holders Sold, Q2 2026 0 institutions, 0 of them sold out
Net change, all compared +103K shares (—)
Net change, active managers +20K shares (—), 1 bought, 0 sold
Buyers versus sellers
11 bought 0 sold
Active managers and hedge funds 1 bought · 0 sold · +20K
Index fund managers 2 bought · 0 sold · +8,513
Other institutions 8 bought · 0 sold · +75K
Biggest buyers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Jane Street Group, LLC | +52K New position | 52K | $260,168 |
| Citadel Advisors LLC Hedge fund | +20K New position | 20K | $99,511 |
| HRT Financial LP | +14K New position | 14K | $67,000 |
| Vanguard Fiduciary Trust Co Index funds | +6,510 New position | 6,510 | $32,485 |
| Tower Research Capital LLC (TRC) | +4,117 New position | 4,117 | $20,544 |
| Connective Capital Management, LLC | +3,338 New position | 3,338 | $16,657 |
| Vanguard Capital Management LLC Index funds | +2,003 New position | 2,003 | $9,995 |
| Golden State Wealth Management, LLC | +1,667 New position | 1,667 | $8,318 |
| Barclays PLC | +191 New position | 191 | $953 |
| Osaic Holdings, Inc. | +4 New position | 4 | $20 |
| UBS Group AG | +1 New position | 1 | $5 |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Citadel Advisors LLC Hedge fund | +20K New position | 20K | $99,511 |
Biggest sellers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| No institution cut its holding. | |||
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| None of the active managers on our list. | |||
New positions
| Institution | Shares | Value June 30, 2026 |
|---|---|---|
| Jane Street Group, LLC | 52K | $260,168 |
| Citadel Advisors LLCHedge fund | 20K | $99,511 |
| HRT Financial LP | 14K | $67,000 |
| Vanguard Fiduciary Trust CoIndex funds | 6,510 | $32,485 |
| Tower Research Capital LLC (TRC) | 4,117 | $20,544 |
| Connective Capital Management, LLC | 3,338 | $16,657 |
| Vanguard Capital Management LLCIndex funds | 2,003 | $9,995 |
| Golden State Wealth Management, LLC | 1,667 | $8,318 |
| Barclays PLC | 191 | $953 |
| Osaic Holdings, Inc. | 4 | $20 |
Sold out
| Institution | Shares | Value March 31, 2026 |
|---|---|---|
| No institution sold its whole holding. | ||
Who holds the shares
- Institutions reporting
- 11
- Ten largest holders
- 100.0% of 13F-reported shares
- Index fund managers
- 8.2% of 13F-reported shares
- Active managers and hedge funds
- 19.3% of 13F-reported shares
| Type | Bought | Sold | New | Sold out | Net change in shares | Net % |
|---|---|---|---|---|---|---|
| Active managers and hedge funds | 1 | 0 | 1 | 0 | +20K | — |
| Index fund managers | 2 | 0 | 2 | 0 | +8,513 | — |
| Other institutions | 8 | 0 | 8 | 0 | +75K | — |